Phase 2 consisted of 52 weeks ' maintenance in either group D , E , or C. Outcomes were changes from randomization in pain on a 100-mm visual analog scale , weight , and response according to the Outcome Measures in Rheumatology-Osteoarthritis Research Society International criteria .